ENZC Enzolytics, Inc.Stock Price & Overview
$0.05-0.0018 (-3.67%)4:00 PM 09/20/23
Pink Current Info | $USD | Post-Market: $0.04 -0.00 (-5.50%) 4:01 PM
Enzolytics Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics. In addition, the company’s proprietary cell line produces human monoclonal antibodies that target and neutralizes the HIV virus. Enzolytics Inc. is based in Plano, Texas.